The global biohacking market size was estimated to be US$ 19 billion in 2021 and is expected grow at a CAGR of 20% between 2023 to 2032.
Biohacking is the area of bioengineering and biogenetics that deals with the scientific editing of yeast or other organisms to increase their functional similarity to human anatomy. Biohacking experiments involve the use of chemicals, gene editing, or implants to augment the capabilities or attributes of living things.
Given that it involves managing one's own biology using a combination of nutritional, electrical, and medicinal technologies, it is frequently referred to as Do-it-Yourself (DIY) biology. The creation and production of new goods has been inspired by biohacking, which has also permitted the non-scientific community to engage with and explore various areas of technology and synthetic biology. A few examples of the tools that biohacking has produced to analyze the human body include smart drugs, magnetic fingertips, brain sensors, smart blood pressure monitoring health trackers, body sensors, microchips and RFID implants.
Through statistics, biohacking refers to the continuous and constant analysis of variables such as heart rate, steps taken, blood sugar levels, calorie burn, and others. The biohacking market is anticipated to expand at a faster rate during the projected period due to the rising use and acceptance of biohacking products.
The rise in the incidence of chronic disease recurrence, the growing popularity of smart devices and effective treatments, and rising biohacking awareness are all predicted to contribute to the growth of the worldwide biohacking market. But throughout the projection period, the market is anticipated to be constrained by stringent laws governing genetic engineering experiments, a lack of funding for research, a lack of basic knowledge, and cyber security protocols.
The global biohacking market may be divided into five geographic segments: North America, Asia Pacific, Europe, South America, and the Middle East & Africa. During the forecast period, North America is projected to be a strong market for biohacking. The strategic presence of crucial players in the U.S. and Canada is responsible for the region's dominance.
The major players operating in the biohacking market are Apple Inc., The ODIN., Thync Global, Inc., Fitbit, Inc., MOODMETRIC, Health Via Modern Nutrition Inc., Muse, ThrivePort, LLC, Truckmaster, OSTEOSTRONG, Synbiota, SynBioBeta LLC, Grindhouse Wetware and others.
Market Segmentations:
By product:
- Smart drugs
- Sensors
- Strains
- others
By Application
- Synthetic biology
- Genetic engineering
- Forensic science
- Diagnosis & treatment
- Drug testing
By End User
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
